Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery
Scoliosis
About this trial
This is an interventional treatment trial for Scoliosis focused on measuring Congenital Scoliosis, Idiopathic Scoliosis, Spinal Fusion, Post-Operative Pain Management, Infusion Catheter
Eligibility Criteria
Inclusion Criteria:
- Clinical Diagnosis of Congenital Scoliosis
- Clinical Diagnosis of Idiopathic Scoliosis
- Anticipated Spinal Fusion Surgery
Exclusion Criteria:
- Less than 8 years of age
Sites / Locations
- Shriners Hospitals for Children - Los Angeles
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Arm 1
Arm 2
Subjects in arm 1 will intraoperatively have a continuous infusion catheter placed in the paraspinal musculature of the posterior spinal wound. Post-operatively, the catheter will infuse 0.25 - 0.5% (according to patient's weight) Bupivacaine at a rate of 4ml/hr for 72 hours. This is in addition to the standardized PCA pain management.
Subjects in arm 2 will intraoperatively have a continuous infusion catheter placed in the paraspinal musculature of the posterior spinal wound. Post-operatively, the catheter will infuse normal saline at a rate of 4ml/hr for 72 hours. This is in addition to the standardized PCA pain management.